A citation-based method for searching scientific literature

Alan F Schatzberg, Charles DeBattista, Laura C Lazzeroni, Amit Etkin, Greer M Murphy, Leanne M Williams. Am J Psychiatry 2015
Times Cited: 50







List of co-cited articles
485 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.
Manfred Uhr, Alina Tontsch, Christian Namendorf, Stephan Ripke, Susanne Lucae, Marcus Ising, Tatjana Dose, Martin Ebinger, Marcus Rosenhagen, Martin Kohli,[...]. Neuron 2008
248
44

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
32

ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.
Barbara Breitenstein, Tanja Maria Brückl, Marcus Ising, Bertram Müller-Myhsok, Florian Holsboer, Darina Czamara. Am J Med Genet B Neuropsychiatr Genet 2015
37
37

Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study.
Barbara Breitenstein, Sandra Scheuer, Tanja Maria Brückl, Jobst Meyer, Marcus Ising, Manfred Uhr, Florian Holsboer. J Psychiatr Res 2016
36
38

Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Bruce A Arnow, Christine Blasey, Leanne M Williams, Donna M Palmer, William Rekshan, Alan F Schatzberg, Amit Etkin, Jayashri Kulkarni, James F Luther, A John Rush. Am J Psychiatry 2015
100
22

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
22

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
Masaki Kato, Tsuyoshi Fukuda, Alessandro Serretti, Masataka Wakeno, Gaku Okugawa, Yuka Ikenaga, Yuka Hosoi, Yoshiteru Takekita, Laura Mandelli, Junichi Azuma,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2008
120
22

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.
A B Singh, C A Bousman, C H Ng, K Byron, M Berk. Transl Psychiatry 2012
57
20

ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression.
Jane E Sarginson, Laura C Lazzeroni, Heather S Ryan, Brent D Ershoff, Alan F Schatzberg, Greer M Murphy. Pharmacogenet Genomics 2010
66
20

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
A John Rush, Madhukar H Trivedi, Jonathan W Stewart, Andrew A Nierenberg, Maurizio Fava, Benji T Kurian, Diane Warden, David W Morris, James F Luther, Mustafa M Husain,[...]. Am J Psychiatry 2011
246
18

The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
Barbara Breitenstein, Sandra Scheuer, Hildegard Pfister, Manfred Uhr, Susanne Lucae, Florian Holsboer, Marcus Ising, Tanja M Brückl. CNS Spectr 2014
35
25

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.
Marianne Gex-Fabry, Chin B Eap, Beatrice Oneda, Nicola Gervasoni, Jean-Michel Aubry, Guido Bondolfi, Gilles Bertschy. Ther Drug Monit 2008
95
18

ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
A Ray, L Tennakoon, J Keller, J E Sarginson, H S Ryan, G M Murphy, L C Lazzeroni, M H Trivedi, J H Kocsis, C DeBattista,[...]. Pharmacogenomics J 2015
20
45


Pharmacogenetics in major depression: a comprehensive meta-analysis.
Tomihisa Niitsu, Chiara Fabbri, Francesco Bentini, Alessandro Serretti. Prog Neuropsychopharmacol Biol Psychiatry 2013
140
18

ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
O L de Klerk, I M Nolte, P M Bet, F J Bosker, H Snieder, J A den Boer, R Bruggeman, W J Hoogendijk, B W Penninx. Pharmacogenomics J 2013
43
18

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
242
16

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy.
Stefano Porcelli, Chiara Fabbri, Alessandro Serretti. Eur Neuropsychopharmacol 2012
209
16

Contribution of common genetic variants to antidepressant response.
Katherine E Tansey, Michel Guipponi, Xiaolan Hu, Enrico Domenici, Glyn Lewis, Alain Malafosse, Jens R Wendland, Cathryn M Lewis, Peter McGuffin, Rudolf Uher. Biol Psychiatry 2013
130
16

Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.
Eric J Peters, Susan L Slager, Jeffrey B Kraft, Greg D Jenkins, Megan S Reinalda, Patrick J McGrath, Steven P Hamilton. PLoS One 2008
125
16

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
526
16

ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients.
Xiaoye Huang, Tao Yu, Xin Li, Yanfei Cao, Xingwang Li, Baocheng Liu, Fengping Yang, Weidong Li, Xinzhi Zhao, Guoyin Feng,[...]. Pharmacogenomics 2013
21
33

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
Daniel K Hall-Flavin, Joel G Winner, Josiah D Allen, Joseph M Carhart, Brian Proctor, Karen A Snyder, Maureen S Drews, Linda L Eisterhold, Jennifer Geske, David A Mrazek. Pharmacogenet Genomics 2013
131
14

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.
Elisabeth B Binder, Daria Salyakina, Peter Lichtner, Gabriele M Wochnik, Marcus Ising, Benno Pütz, Sergi Papiol, Shaun Seaman, Susanne Lucae, Martin A Kohli,[...]. Nat Genet 2004
674
14

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
Chiara Fabbri, Giulia Di Girolamo, Alessandro Serretti. Am J Med Genet B Neuropsychiatr Genet 2013
62
14

The Influence of C3435T Polymorphism of the ABCB1 Gene on Genetic Susceptibility to Depression and Treatment Response in Polish Population - Preliminary Report.
Agnieszka Maria Jeleń, Aleksandra Sałagacka, Marta Karolina Żebrowska, Marek Mirowski, Monika Talarowska, Piotr Gałecki, Ewa Izabela Balcerczak. Int J Med Sci 2015
17
41

Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.
Roy H Perlis, Bonnie Fijal, Sweta Dharia, Alexandra N Heinloth, John P Houston. Biol Psychiatry 2010
59
14

Association between ABCB1 Polymorphisms and Antidepressant Treatment Response in Taiwanese Major Depressive Patients.
Hui Hua Chang, Chen-Hsi Chou, Yen Kuang Yang, I Hui Lee, Po See Chen. Clin Psychopharmacol Neurosci 2015
11
63

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.
Alma Mihaljevic Peles, Nada Bozina, Marina Sagud, Martina Rojnic Kuzman, Mila Lovric. Prog Neuropsychopharmacol Biol Psychiatry 2008
57
14

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Saiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca-García, Eduard Vieta, José M Olivares,[...]. BMC Psychiatry 2017
105
14



Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients.
P Gassó, N Rodríguez, S Mas, M Pagerols, A Blázquez, M T Plana, M Torra, L Lázaro, A Lafuente. Pharmacogenomics J 2014
30
20


ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population.
Gul Ozbey, Berna Yucel, Serap E Taycan, Derya Kan, Nurdan E Bodur, Tayyibe Arslan, Ferda Percin, Nevzat Yuksel, Cuneyt Guzey, Canan Uluoglu. Pharmacol Rep 2014
18
33


The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model.
Angela Doran, R Scott Obach, Bill J Smith, Natilie A Hosea, Stacey Becker, Ernesto Callegari, Cuiping Chen, Xi Chen, Edna Choo, Julie Cianfrogna,[...]. Drug Metab Dispos 2005
347
10

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.
Keh-Ming Lin, Yen-Feng Chiu, I-Ju Tsai, Chia-Hui Chen, Winston W Shen, Shu Chih Liu, Shao-Chun Lu, Chia-Yih Liu, Mei-Chun Hsiao, Hwa-Sheng Tang,[...]. Pharmacogenet Genomics 2011
61
10


A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
10

Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein.
Jun-Sheng Wang, Hao-Jie Zhu, Bryan Bradford Gibson, John Seth Markowitz, Jennifer Lyn Donovan, Carl Lindsay DeVane. Biol Pharm Bull 2008
50
10


Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
Nader Perroud, Guido Bondolfi, Rudolf Uher, Marianne Gex-Fabry, Jean-Michel Aubry, Gilles Bertschy, Alain Malafosse, Markus Kosel. Pharmacogenomics 2011
43
11

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Josiah D Allen, Bryan M Dechairo. Discov Med 2013
119
10

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller. Mol Psychiatry 2004
502
10

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
Marcus Ising, Susanne Lucae, Elisabeth B Binder, Thomas Bettecken, Manfred Uhr, Stephan Ripke, Martin A Kohli, Johannes M Hennings, Sonja Horstmann, Stefan Kloiber,[...]. Arch Gen Psychiatry 2009
225
10

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
296
10

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
Rudolf Uher, Nader Perroud, Mandy Y M Ng, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery,[...]. Am J Psychiatry 2010
254
10

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
651
10

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.
J M Biernacka, K Sangkuhl, G Jenkins, R M Whaley, P Barman, A Batzler, R B Altman, V Arolt, J Brockmöller, C H Chen,[...]. Transl Psychiatry 2015
76
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.